Literature DB >> 13848257

Central vasomotor effects of a new ganglion-blocking agent--1: 2: 2: 6: 6-pentamethyl piperidine (pempidine).

K N DHAWAN, K P BHARGAVA.   

Abstract

The central vasomotor effects of pempidine were studied in dogs and cats anaesthetized with pentobarbitone sodium, and in spinal cats. Pempidine lowered the threshold of electrical stimulation of the medulla oblongata to evoke a pressor response when given intravenously to cats in a dose insufficient to block autonomic ganglia. Injection of a small dose into the cerebral ventricles of dogs produced an increase in the pressor responses to occlusion of the carotid artery and to electrical stimulation of the central end of the cut vagus. In the spinal cat small doses of pempidine, given either intravenously or intrathecally, augmented the rise in blood pressure resulting from compression of the spinal cord. Since all these effects were produced by pempidine in doses insufficient to cause ganglionic block, the observed effects are attributed to central facilitation of the vasomotor responses. Thus pempidine has a stimulant action on the spinal and supraspinal centres.

Entities:  

Keywords:  VASOMOTOR SYSTEM/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 13848257      PMCID: PMC1481938          DOI: 10.1111/j.1476-5381.1960.tb01233.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  5 in total

1.  Pharmacology and clinical use of pempidine in the treatment of hypertension.

Authors:  M HARINGTON; P KINCAID-SMITH; M D MILNE
Journal:  Lancet       Date:  1958-07-05       Impact factor: 79.321

2.  Effects of stimulants and of ganglionic blocking agents on carotid chemoreceptors.

Authors:  A S DONTAS; M NICKERSON
Journal:  Arch Int Pharmacodyn Ther       Date:  1956-05-01

3.  [Diversity of structure of gangliolytic substances].

Authors:  P ZAMBONI; A BORGHETTI
Journal:  Boll Soc Ital Biol Sper       Date:  1953-05

4.  Pharmacological properties of pempidine (1:2:2:6:6-pentamethylpiperidine), a new ganglion-blocking compound.

Authors:  S J CORNE; N D EDGE
Journal:  Br J Pharmacol Chemother       Date:  1958-09

5.  The central vasomotor effects of 5-hydroxytryptamie.

Authors:  K P BHARGAVA; K K TANGRI
Journal:  Br J Pharmacol Chemother       Date:  1959-12
  5 in total
  1 in total

1.  DEPRESSION OF THE VASOMOTOR CENTRE BY MECAMYLAMINE, INDEPENDENT OF ITS GANGLION-BLOCKING ACTIVITY.

Authors:  K P BHARGAVA; K N DHAWAN
Journal:  Br J Pharmacol Chemother       Date:  1963-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.